Blastic Plasmacytoid Dendritic Cell - 11 Studies Found
Active, not recruiting |
: An Open-label Phase II Study of Lorvotuzumab Mertansine : Leukemia : 2015-04-15 : Drug: Lorvotuzumab Mertansine (IMGN901) 100 mg/m2 by vein on Day 1 and 8 of a 21-day cycle. |